QTXB.OB: Summary for QUANTRX BIOMEDICAL - Yahoo! Canada Finance

	Sign In [New User? Sign Up]	Finance Home \|Help

Wednesday, February 10, 2010, 3:56am EST - Canadian Markets open in 5 hours and 34 minutes.

To create a watchlist or portfolio of shares, Sign-in or Register

QuantRX Biomedical Corporation (QTXB.OB)

On Feb 9: 0.35 USD 0.00 (0.00%)

MORE ON QTXB.OB

Quotes

Summary

Charts

News & Info

Company

Analyst Coverage

Ownership

Financials

QUANTRX BIOMEDICAL (OTC BB:QTXB.OB) Delayed quote data

Last Trade:	0.35 USD
Trade Time:	Feb 9
Change:	0.00 (0.00%)
Prev Close:	0.35
Open:	N/A
Bid:	N/A
Ask:	N/A
1y Target Est:	N/A

Day's Range:	N/A - N/A
52wk Range:	0.18 - 0.59
Volume:	0
Avg Vol (3m):	19,228.6
Market Cap:	15.55M
P/E (ttm):	N/A
EPS (ttm):	-0.08
Div & Yield:	N/A (N/A%)

QuantRX Biomedical Corporation (QTXB.OB)

1d 5d 3m 6m 1y 2y 5y

Add QTXB.OB to Portfolio

Download Data

HEADLINES

•	QUANTRX BIOMEDICAL CORP Files SEC form 8-K, Entry into a Material Definitive Agreement, Other Events, Financial State
	EDGAR Online (Fri, Jan 29)

•	QuantRx Biomedical to Acquire NuRx Pharmaceuticals
	Business Wire (Fri, Jan 29)

•	QuantRx CEO Provides Update on Genetics-based Personalized Medicine and Disease Prevention Platform Technology
	Business Wire (Tue, Jan 19)

•	QuantRx to Present at OneMedForum 2010 Finance Conference
	Business Wire (Mon, Jan 11)

•	QuantRx Celebrates Successful Debut of Flagship Diagnostic Reader Device (Q-Reader) at MEDICA 2009
	Business Wire (Tue, Dec 8)

•	QUANTRX BIOMEDICAL CORP Financials
	EDGAR Online Financials (Sat, Nov 21)

•	QUANTRX BIOMEDICAL CORP Files SEC form 10-Q, Quarterly Report
	EDGAR Online (Mon, Nov 16)

•	QUANTRX BIOMEDICAL CORP Files SEC form 8-K/A, Unregistered Sale of Equity Securities
	EDGAR Online (Fri, Aug 14)

•	QUANTRX BIOMEDICAL CORP Files SEC form 8-K, Entry into a Material Definitive Agreement, Termination of a Material Def
	EDGAR Online (Wed, Aug 5)

•	QUANTRX BIOMEDICAL CORP Files SEC form 10-Q, Quarterly Report
	EDGAR Online (Fri, May 15)

More Headlines for QTXB.OB...

ANALYST

EPS Est (next year) (Dec-69) :	N/A
EPS Est (in 2 years) (Dec-69) :	N/A
Avg Rec (current)*:	N/A
PEG Ratio:	N/A

* (Strong Buy) 1.0 - 5.0 (Strong Sell)

Analyst Opinion - Estimates

BUSINESS SUMMARY

QuantRx Biomedical Corporation, a diagnostics company, focuses on the development and commercialization of diagnostic products based on its patented technology platforms for the worldwide healthcare industry.

Full Company Profile

Add to Portfolio

Email to a Friend

•